货号:GS40619
Rolinsatamab is a chimeric IgG1 kappa monoclonal antibody targeting the prolactin receptor (PRLR). It blocks PRLR signaling, which is involved in cell proliferation and survival pathways. It is being developed for the treatment of PRLR-positive cancers, such as certain breast and prostate cancers.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物